Borrelia Mayonii: Symptoms, Diagnosis, and Treatment
A rare cause of Lyme disease
Atypical symptoms and high levels of bacteria in the blood
What testing, treatment, and new cases reveal
Borrelia mayonii is a rare species of bacteria that causes Lyme disease. Although it can produce symptoms associated with infection by Borrelia burgdorferi, patients may also develop unusually high fever, nausea, vomiting, diffuse rash, confusion, and high levels of spirochetes in the blood.
Borrelia mayonii was identified as a cause of Lyme disease in 2016 after investigators examined unusual blood test results from patients in Minnesota and Wisconsin. It belongs to the Borrelia burgdorferi sensu lato group but appears to produce a somewhat different pattern of illness.
Early reports suggested that the organism was limited to the Upper Midwest. However, a 2026 report describing a locally acquired infection in New York indicates that its recognized geographic distribution now extends beyond the Upper Midwest.
What Is Borrelia Mayonii?
Borrelia mayonii is a spiral-shaped bacterium, or spirochete, transmitted by the blacklegged tick, Ixodes scapularis. The same tick can transmit Borrelia burgdorferi, the most commonly recognized cause of Lyme disease in the United States.
The organism was discovered after Mayo Clinic researchers found unusually high quantities of spirochetes in blood samples from patients with suspected Lyme disease. Genetic analysis showed that the organism was a separate species within the Lyme disease group.
Like other Lyme disease infections, B. mayonii may begin with fever, headache, muscle pain, joint pain, fatigue, and a rash. However, several features reported in patients have been less typical of Lyme disease caused by B. burgdorferi.
Borrelia Mayonii Symptoms
The full clinical spectrum of Borrelia mayonii infection remains uncertain because relatively few human cases have been described. Reported symptoms have included:
- High fever
- Shaking chills
- Severe headache
- Fatigue and generalized weakness
- Muscle and joint pain
- Neck pain
- Nausea or vomiting
- Diffuse or patchy macular rash
- Confusion or encephalopathy
- Shortness of breath
These symptoms overlap with other Lyme disease symptoms and with illnesses such as anaplasmosis, ehrlichiosis, babesiosis, and tick-borne relapsing fever.
The rash may not resemble the classic expanding erythema migrans rash associated with Lyme disease. Some patients have developed large areas of patchy or diffuse redness across the trunk or other parts of the body.
How Borrelia Mayonii May Differ From Borrelia Burgdorferi
One of the most notable findings in human B. mayonii infections has been unusually high spirochetemia, meaning large numbers of spirochetes circulating in the bloodstream.
In the original patient series, the concentration of B. mayonii in the blood was substantially higher than levels ordinarily reported with B. burgdorferi. In some cases, the spirochetes could be seen on a routine blood smear—an unusual finding in Lyme disease.
Clinical features that may suggest B. mayonii include:
- Higher fever
- Diffuse or patchy macular rash
- Nausea and vomiting
- Confusion or altered mental status
- High concentrations of spirochetes in the blood
These differences do not mean that every patient will have an atypical presentation. Patients may still develop symptoms that closely resemble Lyme disease caused by B. burgdorferi.
Atypical Borrelia Mayonii Case in Minnesota
McGowan and colleagues described an acute Borrelia mayonii infection in a 51-year-old man from northern Minnesota.
The man was hospitalized after two days of fever, shaking chills, intense headache, intermittent confusion, diffuse joint pain, dry cough, generalized weakness, and mild shortness of breath.
During the previous two weeks, he had been felling trees and clearing brush on his rural Minnesota property, creating substantial potential exposure to infected ticks.
On examination, physicians noted patches of confluent macular erythema across his torso. This differed from the more familiar expanding erythema migrans rash associated with Lyme disease.
PCR testing of his blood was positive for Borrelia mayonii. Other Lyme disease species, including B. burgdorferi, B. garinii, and B. afzelii, were not detected.
The patient was initially treated with intravenous ceftriaxone and then transitioned to doxycycline. He improved with treatment.
The authors emphasized that patchy macular erythema, high fever, and encephalopathy were not typical features of infection with B. burgdorferi. However, each had been reported in at least half of the patients in the original B. mayonii series.
Borrelia Mayonii Detected in New York
A 2026 report from the New York State Department of Health described the first known locally acquired Borrelia mayonii infection in New York.
The Herkimer County resident became ill with symptoms consistent with a tick-borne infection in late June 2025. PCR testing was positive for B. mayonii, and the patient was also infected with Anaplasma phagocytophilum, the bacterium that causes anaplasmosis.
The patient reported outdoor exposure but no recent travel, blood transfusion, or organ transplant. The patient was treated with doxycycline and recovered.
Investigators collected blacklegged ticks from the wooded property surrounding the patient’s residence. One nymph tested positive for B. mayonii. Later sampling identified nine additional positive adult ticks from the same property.
The nymphal infection rate on the property was 0.7% (1 of 147), while 3.9% of the adult ticks collected there during the later survey were positive (9 of 229). Investigators suggested that this pattern was more consistent with an established local transmission cycle involving a vertebrate reservoir, such as mice or squirrels, than with the accidental arrival of a single infected tick.
Several of the positive ticks carried more than one pathogen. One infected nymph also carried B. burgdorferi and Anaplasma phagocytophilum, while four positive adult ticks were also infected with B. burgdorferi.
The findings provide evidence of an established local focus of B. mayonii transmission in New York rather than an isolated infected tick transported from the Midwest.
However, the report does not show that B. mayonii is widespread across New York. Investigators screened 1,518 ticks collected from 24 counties during 2021–2025. The only positive ticks came from the Herkimer County case property. Continued surveillance will be needed to determine whether the organism is present elsewhere in the state.
This report also demonstrates why clinicians should consider tick-borne coinfections when a patient has severe, overlapping, or atypical symptoms after tick exposure.
How Is Borrelia Mayonii Diagnosed?
Diagnosis can be difficult because the symptoms overlap with other forms of Lyme disease and several other tick-borne infections.
Testing may include:
- PCR testing of whole blood
- Microscopic examination of a blood smear
- Lyme disease antibody testing
- Testing for additional tick-borne pathogens
PCR may be particularly useful during acute illness because B. mayonii can produce higher levels of bacteria in the bloodstream than are usually found with B. burgdorferi.
However, a negative PCR test does not necessarily exclude Lyme disease. The amount of circulating bacterial DNA can change during infection, and test performance may depend on when the sample is collected.
Blood smear examination may occasionally identify visible spirochetes, but this finding should be confirmed with molecular testing because other Borrelia species can also circulate at detectable levels.
Antibody testing may support the diagnosis, but physicians must consider the timing of testing. Antibodies may not yet be detectable during the earliest stage of illness. The limitations of early testing are discussed further in Why Lyme Disease Tests Can Be Negative Early.
When Should Borrelia Mayonii Be Considered?
Physicians may consider B. mayonii when a patient develops an acute tick-borne illness with atypical features, particularly:
- High fever
- Patchy or diffuse macular rash
- Confusion or encephalopathy
- Nausea or vomiting
- Visible spirochetes on a blood smear
Although exposure in Minnesota and Wisconsin remains relevant, the New York findings demonstrate that geographic assumptions should not be used to exclude the diagnosis.
A broad diagnostic evaluation may be appropriate when an acutely ill patient has spent time in wooded or brush-covered areas and has symptoms compatible with more than one tick-borne infection.
Borrelia Mayonii Treatment
There are no clinical trials focused specifically on the treatment of Borrelia mayonii. Because of the limited published experience, clinicians generally use antibiotics recommended for Lyme disease, tailoring treatment to the patient’s clinical presentation.
Depending on the severity and manifestations of illness, treatment may include doxycycline, amoxicillin, cefuroxime, or intravenous ceftriaxone. The appropriate antibiotic, route, and duration depend on the patient’s age, symptoms, disease severity, neurologic or cardiac involvement, medication tolerance, and possible coinfections.
The Minnesota patient described by McGowan and colleagues improved after intravenous ceftriaxone followed by doxycycline. The New York patient, who was also diagnosed with anaplasmosis, recovered after doxycycline treatment.
Patients with severe neurologic symptoms, cardiac abnormalities, altered mental status, or systemic illness may require hospitalization and a more extensive evaluation. Treatment decisions should be individualized rather than based only on the name of the infecting Borrelia species.
New Research on Carditis and Arthritis
A 2026 laboratory study compared infection with Borrelia mayonii and Borrelia burgdorferi in Lyme-susceptible mice.
The researchers found that both organisms could produce inflammation in cardiac tissue. At four weeks, carditis was found in 5 of 10 mice infected with B. mayonii, compared with 9 of 10 mice infected with B. burgdorferi.
However, the pattern was different in the joints. Mice infected with B. burgdorferi developed joint swelling, synovitis, edema, and other evidence of arthritis. The mice infected with B. mayonii did not develop measurable joint swelling or joint inflammation during the four-week study.
The findings suggest that different Lyme disease species may produce different patterns of tissue involvement. However, this was an animal study and does not establish that human B. mayonii infection cannot cause arthritis.
Joint pain and diffuse muscle pain have been reported in human cases, but too few patients have been studied to determine the risk of objective Lyme arthritis. Additional human studies are needed to better understand how B. mayonii affects the joints and heart.
Why Continued Surveillance Matters
The small number of recognized cases does not necessarily establish how often B. mayonii infection occurs. Cases may be missed because testing is not routinely species-specific, clinicians may be unfamiliar with its atypical manifestations, and symptoms may be attributed to B. burgdorferi or another tick-borne infection.
The discovery of locally infected ticks in New York illustrates how the known distribution of emerging pathogens can change as surveillance and molecular testing improve.
Continued testing of patients, ticks, and animal reservoirs will be necessary to determine where B. mayonii is established and how frequently it contributes to human illness.
Frequently Asked Questions
What is Borrelia mayonii?
Borrelia mayonii is a species of tick-borne bacterium that causes Lyme disease. It is transmitted by blacklegged ticks and was first identified in patients from Minnesota and Wisconsin.
What are the symptoms of Borrelia mayonii infection?
Symptoms may include fever, chills, severe headache, fatigue, muscle and joint pain, diffuse rash, nausea, vomiting, confusion, and weakness. Some patients have unusually high levels of spirochetes in their blood.
Where has Borrelia mayonii been found?
Human infections and infected ticks were initially reported in Minnesota and Wisconsin. In 2025, a locally acquired human infection and multiple infected ticks were identified on a property in Herkimer County, New York.
Is Borrelia mayonii widespread in New York?
Not based on current evidence. Investigators screened 1,518 ticks collected from 24 New York counties, but the only positive ticks came from the Herkimer County property associated with the human case. The finding establishes localized transmission, not statewide spread.
How is Borrelia mayonii diagnosed?
Diagnosis may involve PCR testing of whole blood, Lyme disease antibody testing, and occasionally microscopic examination of a blood smear. Patients should also be evaluated for other tick-borne infections when clinically appropriate.
How is Borrelia mayonii treated?
Because no treatment trials have focused specifically on Borrelia mayonii, clinicians generally use antibiotics recommended for Lyme disease. The choice of treatment depends on the patient’s symptoms, disease severity, and the presence of neurologic, cardiac, or other tick-borne coinfections.
Can Borrelia mayonii cause carditis or arthritis?
A 2026 mouse study found that Borrelia mayonii produced carditis but not arthritis during the four-week experiment. Human cases have reported joint pain, but there are currently too few published cases to determine the risk of objective Lyme arthritis.
Clinical Takeaway
Borrelia mayonii remains a rare but clinically important cause of Lyme disease. High fever, diffuse macular rash, nausea, vomiting, encephalopathy, or unusually high levels of spirochetes in the blood may provide clues to the diagnosis.
The identification of a locally acquired case and infected ticks in New York demonstrates that the recognized geographic range of B. mayonii extends beyond the Upper Midwest. Clinicians should also consider the possibility of coinfections when evaluating patients with severe or atypical tick-borne illness.
When patients present with an unusual Lyme disease syndrome, diagnosis should be guided by the complete clinical picture, appropriate laboratory testing, and consideration of other tick-borne pathogens.
Related Articles
Learn more about emerging Borrelia species, Lyme disease diagnosis, and associated tick-borne infections:
What Is Borrelia miyamotoi? Symptoms, Testing, and Treatment
Why Lyme Disease Tests Can Be Negative Early
Lyme Disease Coinfections: Symptoms, Diagnosis, and Treatment
Anaplasmosis Neurologic Symptoms and Brain Involvement
Lyme Disease Rash: Recognizing Early Skin Changes
References
- Pritt BS, Mead PS, Hoang Johnson DK, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016;16(5):556-564.
- Pritt BS, Respicio-Kingry LB, Sloan LM, et al. Borrelia mayonii sp. nov., a member of the Borrelia burgdorferi sensu lato complex, detected in patients and ticks in the upper midwestern United States. Int J Syst Evol Microbiol. 2016;66(11):4878-4880.
- McGowan MS, Kalinoski TM, Hesse SE. Acute Lyme disease with atypical features due to Borrelia mayonii. Open Forum Infect Dis. 2023;10(11):ofad524.
- Cleveland DW, Wijetunga N, Casselli T, et al. Borrelia mayonii induces carditis but not arthritis in Lyme-susceptible mice. Front Immunol. 2026;17:1727413.
- Nafiz TN, Prusinski MA, Gubbala S, et al. Notes from the Field: Borrelia mayonii Lyme Disease—New York, 2025. MMWR Morb Mortal Wkly Rep. 2026;75(21):271-272.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention

Get Health Insights from Dr. Daniel Cameron